Felodipine是长效的钙离子通道阻断剂。
Felodipine is a selective L-type Ca2+ channel blocker with IC50 of 0.15 nM.
1 g/kg/day口服处理
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Johnson JD, et al. J Pharmacol Exp Ther, 1983, 226(2), 330-334.
分子式 C18H19Cl2NO4 |
分子量 384.25 |
CAS号 72509-76-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO >25 mg/mL |
Water <1 mg/mL |
Ethanol >25 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02232269 | Food-Drug Interactions | Other: Black Coffee|Other: Grapefruit Juice|Other: Water|Drug: Felodipine | Lawson Health Research Institute | Phase 1 | 2012-02-01 | 2014-09-02 |
NCT01136863 | Hypertension | Drug: Felodipine|Drug: Placebo | Chinese Academy of Medical Sciences|Shanxi Kangbao Pharmaceutical company|Beijing Hypertension League Insititute | 1998-04-01 | 2010-06-23 | |
NCT02311530 | Healthy | Drug: Felodipine|Drug: Felodipine (Plendil) | Ranbaxy Laboratories Limited|Ranbaxy Inc. | 2008-10-01 | 2014-12-05 | |
NCT02327247 | Healthy | Drug: Felodipine|Drug: PLENDIL庐 | Ranbaxy Laboratories Limited|Ranbaxy Inc. | 2008-09-01 | 2014-12-23 | |
NCT02336607 | Hypertension | Drug: Felodipine tablet (Plendil) alone|Drug: Felodipine tablet (Plendil)+Hydrochlorothiazide|Drug: Felodipine tablet (Plendil)+Metoprolol tablet (Betaloc ZOK)|Drug: Felodipine tablets (Plendil)+Lisinopril (Zestril) | AstraZeneca | 2005-12-01 | 2015-03-13 | |
NCT00507845 | Hypertension | Drug: Ramipril-Felodipine | Sanofi | Phase 4 | 2007-06-01 | 2009-04-16 |
NCT01520285 | Hypertension | Drug: Zanidip|Drug: Felodipine sustained-release tablet | Lee's Pharmaceutical Limited | Phase 4 | 2011-12-01 | 2014-10-14 |
NCT00905333 | Healthy | Drug: Candesartan (test)|Drug: Felodipine (test)|Drug: Candesartan Cilexetil|Drug: Felodipine | AstraZeneca|Scentryphar Clinical Research|Cori Analyticals|Clnica So Lucas, Hospital Srio Libans de Itatiba S/C|LabClin Laboratrio Clnico|Laborat贸rio de Patologia Clnica Dr. Franceschi Ltda.|Faculdade de Cincias Farmacuticas de Ribeiro Preto - Centro de Bioequivalncia | Phase 1 | 2008-10-01 | 2010-12-06 |
NCT01630902 | Healthy | Drug: Torrent's Felodipine Extended-Release Tablets | Torrent Pharmaceuticals Limited | Phase 1 | 2012-06-27 | |
NCT01630655 | Healthy | Drug: Torrent's Felodipine Extended-Release Tablets | Torrent Pharmaceuticals Limited | Phase 1 | 2012-06-27 | |
NCT01238705 | Hypertension|Sexual Dysfunction | Drug: Felodipine add Irbesartan|Drug: Felodipine add Metoprolol | LanZhou University | Phase 4 | 2008-04-01 | 2010-11-10 |
NCT00841880 | Hypertension | Drug: Ramipril + Felodipine|Drug: Ramipril|Drug: Ramipril | Sanofi | Phase 4 | 2009-01-01 | 2010-08-26 |
NCT02744872 | Disorder Related to Lung Transplantation | Drug: Felodipine|Drug: Placebo | Rigshospitalet, Denmark | Phase 4 | 2013-09-01 | 2016-10-05 |
NCT00367939 | Hypertension | Drug: valsartan + amlodipine | Novartis | Phase 3 | 2005-12-01 | 2011-11-07 |
NCT00861016 | Hypertension | Drug: metoprolol succinate prolonged-release tablet and felodipine | AstraZeneca | Phase 4 | 2005-10-01 | 2009-03-12 |
NCT00392262 | Hypertension | Drug: valsartan + amlodipine | Novartis | Phase 3 | 2006-08-01 | 2016-11-16 |
NCT00742066 | Hypertension|Insulin Resistance|Microcirculation | Drug: Irbesartan|Drug: Felodipine|Drug: Placebo | Maastricht University Medical Center | 2008-03-01 | 2011-03-16 | |
NCT00348686 | Hypertension|Left Ventricular Hypertrophy | Drug: Candesartan|Drug: Candesartan|Drug: Felodipine|Drug: Felodipine | AstraZeneca | Phase 4 | 2006-06-01 | 2012-03-05 |
NCT00679653 | Obesity|Hypertension | Drug: sibutramine|Drug: sibutramine|Drug: verapamil/trandolapril|Drug: metoprolol/HCT|Drug: felodipine/ramipril | Abbott | Phase 3 | 2002-02-01 | 2008-05-16 |
NCT00684489 | Hypertension | Drug: clinical hypertension specialist-no specific med. Any anti-hypertension meds.|Drug: renin guided therapeutics-no specific med. Any anti-hypertensive med. | Medical University of South Carolina|New York Presbyterian Hospital | 2003-09-01 | 2008-05-22 | |
NCT00582114 | Hemodialysis|Hypertension|Left Ventricular Hypertrophy | Drug: Lisinopril|Drug: Atenolol | Indiana University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 | 2005-08-01 | 2015-12-14 |
NCT02988102 | Biomarkers | Other: Following S100B and NSE in head trauma | University Clinical Centre of Kosova | 2016-12-01 | 2016-12-08 | |
NCT00000620 | Atherosclerosis|Cardiovascular Diseases|Hypercholesterolemia|Hypertension|Diabetes Mellitus, Type 2|Diabetes Mellitus|Coronary Disease | Drug: Anti-hyperglycemic Agents|Drug: Anti-hypertensive Agents|Drug: Blinded fenofibrate or placebo plus simvastatin | National Heart, Lung, and Blood Institute (NHLBI)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institute on Aging (NIA)|National Eye Institute (NEI)|Centers for Disease Control and Prevention | Phase 3 | 1999-09-01 | 2016-11-21 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们